[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-nihr-eme-programme-researcher-led-2026":3,"similar-nihr-eme-programme-researcher-led-2026":27},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":8,"budget_max_eur":8,"deadline":8,"deadline_note":8,"duration":8,"trl":8,"relevance":8,"why_relevant":8,"early_career":9,"consortium":8,"first_seen":10,"last_updated":8,"update_note":8,"status":11,"stages":12,"call_frequency":8,"next_call_expected":8,"source_url":7,"created_at":13,"updated_at":14,"eligible_countries":15,"description":17,"seo_summary":18,"recurring_round":9,"canonical_id":4,"links":19},"nihr-eme-programme-researcher-led-2026","EME Programme Researcher-Led","NIHR","https:\u002F\u002Fwww.nihr.ac.uk\u002Ffunding\u002Feme-programme-researcher-led\u002F2026483",null,false,"2026-08-13T00:00:00.000Z","open","2-stage: outline application → full application","2026-08-13T10:30:56.954Z","2026-08-14T05:55:12.580Z",[16],"GB","Funds clinical trials and mechanistic studies evaluating efficacy of promising health interventions. Requires proof of concept in humans, patient\u002Fpublic involvement, and hypothesis-driven design. Clinical trials must engage an accredited UKCRC CTU and comply with UK MHRA regulations. Lead applicant's employing institution must act as sponsor. UK-based host institutions.","{\"summary\":\"The NIHR EME Programme Researcher-Led funds clinical trials and mechanistic studies testing the efficacy of promising health interventions in UK settings. The call targets researchers with proof-of-concept evidence and hypothesis-driven designs; clinical trials must partner with an accredited UKCRC Clinical Trials Unit and comply with UK MHRA regulations. Patient and public involvement is mandatory.\",\"meta_description\":\"NIHR EME Programme funds clinical trials and efficacy studies of health interventions in UK settings with UKCRC CTU partnership, from NIHR.\",\"who_should_apply\":[\"Researchers based at UK-hosting institutions with proven organisational research support\",\"Clinical trial teams with accredited UKCRC CTU partnership already in place\",\"Applicants with preliminary human proof-of-concept data or mechanistic evidence\",\"Projects with structured patient and public involvement embedded in design\"],\"key_dates\":[\"Two-stage evaluation: outline application → full application and review\"],\"tips\":[\"CTU partnership is non-negotiable for clinical trials; confirm accreditation and capacity before submission.\",\"Patient\u002Fpublic involvement is assessed as part of feasibility; involve PPI representatives early in proposal shaping, not as an afterthought.\",\"Lead applicant's institution must formally act as sponsor; clarify sponsorship governance with your research office before drafting the outline.\"],\"faq\":[{\"q\":\"What types of research does NIHR EME fund?\",\"a\":\"Clinical trials and mechanistic studies evaluating the efficacy of promising health interventions, with proof-of-concept evidence in humans and hypothesis-driven designs.\"},{\"q\":\"Do I need a Clinical Trials Unit for NIHR EME funding?\",\"a\":\"Clinical trials must partner with an accredited UKCRC Clinical Trials Unit and comply with UK MHRA regulations; mechanistic studies do not have this requirement.\"},{\"q\":\"Where can I host an NIHR EME project?\",\"a\":\"Host institutions must be UK-based. Your employing institution will act as the project sponsor.\"},{\"q\":\"Is patient involvement required for NIHR EME?\",\"a\":\"Yes, patient and public involvement is mandatory and assessed as part of the application.\"}],\"tags\":[\"nihr\",\"clinical-trials\",\"efficacy-studies\",\"uk-based\",\"hypothesis-driven\",\"patient-involvement\",\"mechanistic-research\"]}",{"matchedProgram":8,"resourceSlug":8,"relatedGuides":20,"countryHubs":21,"domainHubs":25,"closingMonth":8,"hasRelated":9,"hasBrowseRelated":26},[],[22],{"slug":23,"demonym":24},"gb","UK researchers",[],true,{"grants":28},[29,32,35,38,44],{"id":30,"name":31,"funder":6,"deadline":8,"budget":8},"nihr-efficacy-and-mechanism-evaluation-programme-2026","Efficacy and Mechanism Evaluation Programme",{"id":33,"name":34,"funder":6,"deadline":8,"budget":8},"nihr-james-lind-alliance-priority-setting-partnerships-2026","James Lind Alliance Priority Setting Partnerships",{"id":36,"name":37,"funder":6,"deadline":8,"budget":8},"nihr-hta-researcher-led-primary-research-2026","HTA Researcher-Led Primary Research",{"id":39,"name":40,"funder":41,"deadline":42,"budget":43},"medical-research-council-mrc-mrc-experimental-medicine-2026-10","MRC Experimental Medicine","Medical Research Council (MRC)","2026-10-07T00:00:00.000Z","No limit stated; 80% of full economic cost funded",{"id":45,"name":46,"funder":47,"deadline":48,"budget":49},"mrc-ukri-mrc-proof-of-concept-2026-11","MRC Proof of Concept","MRC (UKRI)","2026-11-04T00:00:00.000Z","No limit stated; 80% FEC funded (100% for permitted exceptions)"]